Volume 25, Number 4—April 2019
Research
Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men
Table 5
Risk factors for detection of macrolide resistance mutations in anogenital Mycoplasma genitalium infections detected in men who have sex with men, Australia
Category |
Mutations not detected, no. (%) |
Mutations detected, no. (%) |
p value |
Overall |
15 (15.8) |
80 (84.2) |
|
Antibiotic in the preceding 3 months | |||
None | 13 (86.7) | 54 (67.5) | |
Yes, not azithromycin | 2 (13.3) | 17 (21.3) | |
Yes, azithromycin |
0 |
9 ( 11.2) |
0.39 |
HIV status | |||
Negative | 15 (100.0) | 75 (93.8) | |
Positive |
0 |
5 ( 6.2) |
1.0 |
Taking or starting PrEP* | |||
No | 15 (100.0) | 59 (78.7) | |
Yes |
0 |
16 (21.3) |
0.06 |
Site of infection | |||
Urine | 4 (26.7) | 23 (28.0) | |
Rectum | 11 (73.3) | 59 (72.2) | 0.91 |
*PrEP, preexposure prophylaxis. HIV-positive men excluded.
Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.